Our top pick for
US stocks
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Simavita is a medical devices business based in Australia. Simavita shares (SVA) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Simavita has a trailing 12-month revenue of around $43,469. If you're looking to buy shares, check out the steps below.
How to buy shares in Simavita
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Simavita . Find the share by name or ticker symbol: SVA. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Simavita reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Simavita . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
ETF investing
Our top pick for
Long-term investing
Simavita stock price (ASX:SVA)
Use our graph to track the performance of SVA stocks over time.Simavita shares at a glance
Information last updated 2021-04-21.
| 52-week range | $0.014 - $0.02 |
|---|---|
| 50-day moving average | $0.0168 |
| 200-day moving average | $0.0178 |
| Target price | $0.05 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.02 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Simavita stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Simavita financials
| Revenue TTM | $43,469 |
|---|---|
| Gross profit TTM | $23,472 |
| Return on assets TTM | -111.45% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | -0.006 |
| Market capitalisation | $47.3 million |
TTM: trailing 12 months
Simavita share dividends
We're not expecting Simavita to pay a dividend over the next 12 months.
Simavita share price volatility
Over the last 12 months, Simavita 's shares have ranged in value from as little as $0.014 up to $0.02. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Simavita 's is -0.7229. This would suggest that Simavita 's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Simavita has bucked the trend.
Simavita overview
Simavita Limited develops smart wearable and disposable sensors for the diaper industry primarily in Australia, North America, and Europe. It offers Smartz, a platform technology linked to phones and tablets that provides indicators, including wetness, ambient temperature, pressure sore management, falls, and other features and information for incontinence pad or diaper to parents and carers of infants and adults. The company was incorporated in 1968 and is headquartered in North Sydney, Australia.
Simavita in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to watch Hobart Ashes Test Australia vs England online
Australia and England meet for an historic Ashes Test in Hobart.
-
Back to school? 6 ways to make it more affordable
SPONSORED: Kids are expensive. Here’s how to save money and manage costs when kitting them out for the new school year.
-
Rapid antigen tests: When will RAT stock be available? [UPDATED]
Rapid antigen tests are proving extremely hard to find, but there are options if you can be patient trying to find a RAT.
-
Rapid antigen tests may be “key” to return to school
Some states are delaying the school year while others discuss using rapid antigen tests in classrooms.
-
Get $29 flights in Jetstar’s first Friday Fare Frenzy of 2022
You'll fall for these Autumn flight deals on dozens of domestic and international routes.
-
Why is the Afterpay (APT) share price on the downslide?
Despite recent gains, shares in BNPL leader Afterpay are down 20% over the past month.
-
Today’s ASX top stocks: Brainchip Holdings (BRN ↑20.7%), City Chic Collective (CCX ↑12.1%)
The 10 biggest movers on the ASX for Friday 14 January 2022.
-
What is a KF94 mask and where can you buy one?
The Korean-designed KF94 mask may offer greater protection than a cloth mask.
-
The 13 hottest hair trends for 2022
Spoiler alert: The shag cut is still in.
-
Interview: RAQ founder talks Abbie Chatfield swim collection
RAQ Apparel founder Sophia Argyropoulos chats the inspo for Abbie Chatfield swimwear collab and the secret to finding the perfect bikini.
Ask an Expert
